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PCoronary Artery Disease
Association of Mortality With Years
of Education in Patients With ST-Segment Elevation
Myocardial Infarction Treated With Fibrinolysis
Rajendra H. Mehta, MD, MS,* J. Conor O’Shea, MD,† Amanda L. Stebbins, MS,*
Christopher B. Granger, MD,* Paul W. Armstrong, MD,‡ Harvey D. White, MB, DSC,§
Eric J. Topol, MD, Robert M. Califf, MD,*¶ E. Magnus Ohman, MD*
Durham, North Carolina; Cork, Ireland; Edmonton, Alberta, Canada; Auckland, New Zealand;
and La Jolla, California
Objectives The purpose of this study was to examine the association between lower socioeconomic status (SES), as ascer-
tained by years of education, and outcomes in patients with acute ST-segment elevation myocardial infarction
(STEMI).
Background Previous studies have shown an inverse relationship between SES and coronary heart disease and mortality.
Whether a similar association between SES and mortality exists in STEMI patients is unknown.
Methods We evaluated 11,326 patients with STEMI in the GUSTO-III (Global Use of Strategies to Open Occluded Coronary
Arteries) trial study from countries that enrolled 500 patients. We evaluated clinical outcomes (adjusted using
multivariate regression analysis) according to the number of years of education completed.
Results One-year mortality was inversely related to years of education and was 5-fold higher in patients with 8 years com-
pared with those with 16 years of education (17.5% vs. 3.5%, p  0.0001). The strength of the relationship be-
tween education and mortality varied among different countries. Nonetheless, years of education remained an inde-
pendent correlate of mortality at day 7 (hazard ratio per year of increase in education: 0.86; 95% confidence interval:
0.83 to 0.88) and also between day 8 and 1 year (hazard ratio per year of increase in education: 0.96; 95% confi-
dence interval: 0.94 to 0.98), even after adjustment for baseline characteristics and country of enrollment.
Conclusions When the number of years of education was used as a measure of SES, there was an inverse relationship such
that significantly higher short-term and 1-year mortality existed beyond that accounted for by baseline clinical
variables and country of enrollment. Future studies should account for and investigate the mechanisms un-
derlying this link between SES and cardiovascular disease outcomes. (J Am Coll Cardiol 2011;57:138–46)
© 2011 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.09.021a
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January 11, 2011:138–46 Education and Mortality in STEMIates in countries such as the United States and the United
ingdom (3–7). In contrast, the burden of disease shifted to
ersons at the lower end of socioeconomic hierarchy and to
ess developed countries where CHD incidence and rates of
ortality are currently higher (2,8–11).
The gap in CHD and its attendant morbidity and
ortality between wealthier and economically underprivi-
eged individuals and between developed and less developed
ountries continues to widen in the recent era (2,12–15). In
act, 80% of CHD mortality has been shown to occur in
oor and less developed countries (1). Thus, the relationship
etween socioeconomic status (SES) and CHD is both
omplex and dynamic, stimulating considerable interest and
erving as the focus of previous investigations. These earlier
tudies have shown that lower SES is linked with signifi-
antly higher prevalence of cardiovascular risk factors such
s hypertension (16); diabetes (17); dyslipidemia (18); cig-
rette smoking (19); obesity, metabolic syndrome, and lack
f physical activity (2,20,21); and hemostatic factors (22),
ccounting for most if not all of the excess risk of CHD in
his population.
Although previous work has evaluated the relationship of
ES with CHD and the risk of myocardial infarction (MI),
ew studies have isolated the association between social class
nd risk of MI from the relationship of social class with
utcomes after the occurrence of this event (23). In addi-
ion, the vast majority of research in this area has reflected
ingle-country or regional experiences, predominantly in-
olving populations in the United States or Scandinavian
ountries (24). Thus, the extrapolation of these findings to
ther regions of the world remains unclear.
Accordingly, the goal of the present study was to examine
he association of SES, as ascertained by years of education,
ith short- and long-term outcomes in a large, international
roup of patients after acute ST-segment elevation myocar-
ial infarction (STEMI). For the purpose of this study, the
atient’s level of education, defined as years of completed
ducation or level of education attained—a generally accept-
ble and widely used surrogate of SES (25)—was used as a
easure of this parameter.
ethods
tudy population. Data from patients enrolled in the
USTO-III (Global Use of Strategies to Open Occluded
oronary Arteries) trial (26) from October 13, 1995,
hrough January 13, 1997, were analyzed for this study. The
etails of the design, methods, and results of the GUSTO-
II trial were previously published (26). In brief, GUSTO-
II investigators enrolled 15,059 patients of any age who
resented within 6 h after the onset of ischemic symptoms
ith electrocardiographic evidence of STEMI. Exclusion
riteria for the trial included active bleeding, a history of
troke or central nervous system damage, recent major
urgery, systolic blood pressure 200 mm Hg or diastolic
lood pressure110 mm Hg at any time after arrival, recent woncompressible vascular punc-
ure, and concomitant use of an
ral anticoagulant with an inter-
ational normalized ratio 2.
atients were randomly assigned
n a 2:1 ratio to receive reteplase
Boehringer Mannheim, Gaith-
rsburg, Maryland, and Mann-
eim, Germany) in 2 bolus doses
f 10 MU given 30 min apart or
n accelerated infusion of alte-
lase (Genentech, South San
rancisco, California, and Boehringer Ingelheim) in a bolus
ose of 15 mg, followed by the infusion of 0.75 mg/kg body
eight over a 30-min period (not to exceed 50 mg) and the
nfusion of 0.5 mg/kg (up to 35 mg) over the next 60 min
n an open-label basis. Aspirin (160 mg) was given as soon
s possible and then in a daily dose of 160 to 325 mg. With
he assigned fibrinolytic therapy, patients received a bolus
ose of 5,000 U of heparin given intravenously, followed by
n infusion of 1,000 U/h. Other medications, including
eta-blockers and nitrates, were given at the discretion of
he investigator.
For the present analyses, we excluded subjects from
ountries with 500 patients enrolled (n  1,806) and
ubjects for whom information on level of education was
issing (n  1,927). The remaining 11,326 subjects form
he basis of this study. Baseline characteristics and clinical
utcomes were compared according to years of education
efore hospital admission.
ata collection, definitions, and outcomes. Data on
emographics, baseline characteristics, medical therapies
uring hospitalization and at discharge, invasive procedure
se, in-hospital adverse clinical events, and 30-day and
-year mortality were collected prospectively (26). All in-
tances of stroke were centrally adjudicated and bleeding
as defined using GUSTO-III criteria (26). In addition,
nformation on years of education (defined as the number of
ull years of school education completed, beginning with
rst grade) was prospectively collected.
The primary end point of GUSTO-III was mortality at
0 days of follow-up (26). Other prospectively defined
econdary end points of the trial included net clinical benefit
efined as freedom from death or disabling stroke, death or
onfatal stroke, reinfarction, congestive heart failure, and
ortality at 24 h (26). Unadjusted in-hospital clinical
utcomes and in-hospital, 30-day, and 1-year mortality, as
ell as adjusted 1-year mortality (data available for 1 full
ear in 97% of patients) were analyzed.
tatistical analyses. For display purposes, we categorized
atients according to years of education as 8 years, 8 to 12
ears, 12 to 16 years, and 16 years. All statistical
nalyses were performed using nonparametric tests with
ears of education as a continuous variable. Discrete factors
Abbreviations
and Acronyms
CHD  coronary heart
disease
MI  myocardial infarction
SES  socioeconomic
status
STEMI  ST-segment
elevation myocardial
infarctionere displayed as frequencies and percentages. Continuous
v
p
f
w
c
a
r
f
a
p
a
t
a
T
o
w
c
r
p
c
d
e
m
c
s
i
t
m
i
Z
f
e
t
a
c
s
C
R
B
u
c
s
y
e
h
i
B
D
140 Mehta et al. JACC Vol. 57, No. 2, 2011
Education and Mortality in STEMI January 11, 2011:138–46ariables were summarized as medians and 25th and 75th
ercentiles. The Spearman rank correlation test was per-
ormed to evaluate the relationship of years of education
ith continuous factors. The association between categori-
al demographics, history, and baseline characteristics vari-
bles and years of education was assessed using Wilcoxon
ank-sum test. The likelihood ratio test statistic p values
rom logistic regression models were reported for the
ssociation between drug therapies, procedures, and com-
lications and years of education. A model was generated to
ssess the relationship among baseline variables (age, sys-
olic blood pressure, heart rate, Killip class at enrollment,
nd MI location), years of education, and 1-year mortality.
he proportional hazards assumption was not met for years
f education because of a very high proportion of patients
ith education 8 years dying early. Hence, 2 models were
reated—one to assess predictors of 0 to 7 days post-
andomization and a second to assess 8 to 365 days
ost-randomization. Together, these 5 variables were asso-
iated with 90% of prognostic information in the baseline
ata from the previously published model (27). Years of
ducation (as a continuous variable) and country of enroll-
ent were then added to this model to assess whether these
ontributed independently to predicting outcome. Chi-
aseline Demographics and Medical History by Years of EducationTable 1 Baseline Demographics and Medical History by Years o
Characteristics
<8 yrs
(n  2,249)
8
(n
Demographics
Age (yrs) 67.9 (60.0, 74.9) 62.1
Female sex 666 (29.6) 2,021
White race 2,131 (94.8) 6,625
Height (cm) 170 (163, 175) 172
Weight (kg) 75 (67, 84) 78
Medical history
Hypertension 838 (37.3) 2,677
Diabetes mellitus 374 (16.6) 1,052
Current smoking 795 (35.8) 3,029
Elevated cholesterol 545 (24.5) 2,459
Previous CHF 76 (3.4) 175
Previous MI 499 (22.2) 1,275
Previous cerebrovascular disease 64 (2.8) 170
Previous PCI 61 (2.7) 353
Previous CABG 72 (3.2) 260
No. of patients by country of enrollment
United Kingdom 522
Germany 221
Sweden 602
Italy 275
New Zealand 15
Poland 132
Canada 164
Australia 153
United States 165ata are presented as median (25th, 75th percentile) or n (%) unless otherwise noted.
CABG  coronary artery bypass graft; CHF  congestive heart failure; MI  myocardial infarction; PCIquare values, p values, hazard ratios, and 95% confidence
ntervals (CIs) were reported. In addition, an interaction
erm of country by years of education was also tested in the
odel described. However, interaction terms were not
ncluded in final models that were reported. Although New
ealand enrolled 500 patients in the trial, it was excluded
rom all models due to the fact that information on years of
ducation was available for 500 patients. All other coun-
ries each contributed 500 patients to the model. For all
nalyses, a 2-tailed p value 0.05 was considered statisti-
ally significant. All analyses were performed using SAS
tatistical software version 8.2 (SAS Institute, Cary, North
arolina).
esults
aseline characteristics, medical therapy, and procedure
se. Of the 11,326 participants in this study, 19.8% had
ompleted 7 years of school, 61.6% had completed high
chool (or equivalent), and 14.4% had between 12 and 16
ears of education; the remaining 4.4% had 16 years of
ducation. Differences in baseline demographics, medical
istory, presenting clinical features, medical therapies, and
n-hospital procedures used in STEMI patients according
ucation
Years of Education
p Value
rs
82)
>12–16 yrs
(n  1,633)
>16 yrs
(n  462)
, 70.6) 58.3 (49.6, 68.3) 57.7 (50.6, 67.5) 0.0001
) 348 (21.3) 61 (13.2) 0.0001
) 1,510 (92.5) 408 (88.5) 0.0030
, 177) 173 (167, 180) 175 (168, 180) 0.0001
9) 80 (72, 90) 80 (73, 91) 0.0001
) 637 (39.0) 194 (42.0) 0.9389
) 230 (14.1) 59 (12.8) 0.0001
) 667 (40.9) 156 (33.9) 0.0001
) 636 (39.0) 190 (41.2) 0.0008
30 (1.8) 7 (1.5) 0.0001
) 281 (17.2) 59 (12.8) 0.0008
29 (1.8) 15 (3.2) 0.3718
100 (6.1) 31 (6.7) 0.0001
71 (4.3) 16 (3.5) 0.0002
89 3 —
83 2 —
76 16 —
73 27 —
30 2 —
64 33 —
309 129 —
48 9 —
861 241 —f Ed
–12 y
 6,9
(52.6
(28.9
(94.9
(165
(70, 8
(38.4
(15.1
(43.5
(35.4
(2.5)
(18.3
(2.4)
(5.1)
(3.7)
794
937
347
135
325
396
1104
727
2217 percutaneous coronary intervention.
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January 11, 2011:138–46 Education and Mortality in STEMIo level of education are shown in Tables 1 and 2. Subjects
ith the least education tended to be older and were more
ikely to be women with a history of diabetes, previous
ongestive heart failure, and MI; however, they were less
ikely to have had previous percutaneous coronary interven-
ions compared with those with more years of education.
resenting features associated with poor prognosis, such as
illip class II or higher and anterior MI location, were also
ore frequent in subjects with the least education. This
ohort also had a greater delay in time to fibrinolytic
herapy, not only because of a longer time from onset of
schemic symptoms to hospital arrival, but also due to longer
oor-to-needle time.
Use of aspirin in-hospital and at time of discharge was
ower in patients with fewer years of education (Table 3).
eta-blockers were used less frequently and angiotensin-
aseline Clinical Features by Years of EducationTable 2 Baseline Clinical Features by Years of Education
Characteristics
<8 yrs
(n  2,249)
Presenting heart rate (beats/min) 73 (62, 87)
Presenting SBP (mm Hg) 137 (120, 153)
Presenting DBP (mm Hg) 80 (70, 90)
Killip class II 458 (20.6)
Location of MI
Anterior 1,141 (50.7) 3
Inferior 997 (44.3) 3
Time to hospital (h) 1.8 (1.1, 2.8)
Time to treatment (h) 2.9 (2.0, 4.0)
Time to randomization (h) 2.6 (1.8, 3.8)
Time from hospital arrival to treatment (h) 1.0 (0.7, 1.5)
ata are presented as median (25th, 75th percentile) or n (%) unless otherwise noted.
DBP  diastolic blood pressure; MI  myocardial infarction; SBP  systolic blood pressure.
n-Hospital Medications, Medications at Discharge, and In-HospitalTable 3 In-Hospital Medications, Medications at Discharge, an
<8 yrs
(n  2,249)
8–12 y
(n  6,9
In-hospital drug therapy
Aspirin 2,206 (98.3) 6,929 (9
Beta-blockers 1,450 (64.5) 5,207 (7
Heparin, any 2,198 (97.7) 6,827 (9
ACE inhibitors 1,085 (48.2) 3,215 (4
Drug therapy at discharge
Aspirin 1,785 (87.6) 6,132 (9
Beta-blockers 1,184 (52.6) 4,257 (6
ACE inhibitors 922 (41.0) 2,719 (3
Procedures
Coronary angiography 1,744 (77.5) 3,857 (5
PCI 226 (10.1) 1,514 (2
CABG 64 (2.8) 522 (7
IABP 26 (1.2) 169 (2
Pulmonary artery catheter 40 (1.8) 250 (3ata are presented as n (%).
ACE  angiotensin-converting enzyme; IABP  intra-aortic balloon pump; other abbreviations as in Tabonverting enzyme inhibitors were used more frequently
mong subjects with less education. Use of coronary angiog-
aphy was more common among subjects with fewer years of
ducation, but percutaneous or surgical coronary revascular-
zation was performed less frequently in this group com-
ared with subjects with more years of education (Table 3).
linical outcomes. In-hospital and 1-year outcomes ac-
ording to years of education in subjects with STEMI are
hown in Table 4. With the exception of in-hospital
leeding, almost all other in-hospital adverse events were
nversely related to years of education. In particular, early
ortality (at 24 h and 30 days) and 30-day mortality and
n-hospital nonfatal stroke were approximately 4- to 13-fold
igher in subjects with 8 years of education compared
ith those with 16 years of education. Similarly, 1-year
ortality was inversely related to number of years of
Years of Education
p Value
2 yrs
6,982)
>12–16 yrs
(n  1,633)
>16 yrs
(n  462)
62, 86) 72 (62, 84) 74 (62, 85) 0.0001
120, 150) 134 (118, 150) 136 (118, 151) 0.0001
70, 90) 80 (70, 90) 80 (70, 91) 0.1569
13.8) 151 (9.3) 30 (6.5) 0.0001
0.0001
47.4) 720 (44.1) 221 (47.8) —
48.9) 863 (52.8) 227 (49.1) —
1.0, 2.5) 1.4 (0.8, 2.3) 1.3 (0.8, 2.0) 0.0001
1.8, 3.8) 2.4 (1.7, 3.5) 2.3 (1.6, 3.2) 0.0001
1.6, 3.5) 2.2 (1.4, 3.2) 2.0 (1.3, 3.0) 0.0001
0.7, 1.4) 0.9 (0.6, 1.3) 0.8 (0.6, 1.3) 0.0001
edures by Years of Educationospital Procedures by Years of Education
rs of Education
p Value
>12–16 yrs
(n  1,633)
>16 yrs
(n  462)
16,151 (99.0) 460 (99.6) 0.0085
1,321 (80.9) 378 (81.8) 0.0001
1,593 (97.6) 447 (96.8) 0.0058
676 (41.4) 179 (38.7) 0.0001
1,451 (90.0) 384 (84.4) 0.0001
1,095 (67.1) 296 (64.1) 0.0001
586 (35.9) 157 (34.0) 0.0001
663 (40.6) 198 (42.9) 0.0001
495 (30.5) 133 (29.0) 0.0001
178 (10.9) 49 (10.6) 0.0001
61 (3.7) 20 (4.3) 0.0001
69 (4.2) 25 (5.4) 0.04328–1
(n 
74 (
135 (
80 (
959 (
,307 (
,417 (
1.6 (
2.6 (
2.3 (
0.9 (Procd In-H
Yea
rs
82)
9.3)
4.6)
7.8)
6.0)
0.0)
1.0)
8.9)
5.3)
1.7)
.5)
.4)
.6)le 1.
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Education and Mortality in STEMI January 11, 2011:138–46ducation (Fig. 1) and was more than 5-fold higher in subjects
ith 8 years of education, compared with those with 16
ears of education (17.5% vs. 3.5%, p  0.0001) (Fig. 2).
inally, patients missing information regarding years of edu-
ation had the highest rates of 1-year mortality (Fig. 2).
ountry of enrollment, years of education, and mortality.
he number of compulsory years of education and the number of
ubjects in each education category varied among countries in the
urrent study (Table 5). Similarly, there was wide variation in
-year mortality rates among countries (Table 5). Nonetheless, for
ost countries included in this study, 1-year mortality was
onsistently higher among subjects with 8 years of education
linical Outcomes by Years of EducationTable 4 Clinical Outcomes by Years of Education
Characteristics
<8 yrs
(n  2,249)
8
(n
In-hospital
Any bleeding 579 (25.8) 2,1
Severe bleeding 16 (0.7)
Stroke 54 (2.4)
Reinfarction 115 (5.1) 2
Congestive heart failure 477 (21.2) 1,1
Cardiogenic shock 139 (6.2) 2
24-h mortality 117 (5.2)
In-hospital mortality 248 (11.0) 2
30-day mortality 270 (12.0) 2
30-day mortality or in-hospital stroke 294 (13.1) 3
ata are given as n (%). Bleeding was assessed according to GUSTO III trial criteria (26).
30%
35%
20%
25%
ity
15%
%
 M
or
ta
l
5%
10%
0%
0 2 4 6 8
Yea
Figure 1 Relationship of Years of Education With 1-Year Morta
Note that increasing years of completed education were associated with decreasin
infarction.ompared with those with 16 years of education (Table 5).
ears of education remained independently correlated with
ortality at day 7 (hazard ratio per year of increase in
ducation: 0.86; 95% confidence interval: 0.83 to 0.88) and also
etween day 8 and 1 year (hazard ratio per year of increase in
ducation: 0.96; 95% confidence interval: 0.94 to 0.98), even
fter adjusting for important baseline variables and country of
nrollment (referent United States) (Table 6). The strength of
he association of years of education with 1-year mortality
iffered among various countries compared with the United
tates, as suggested by significant p values for the interaction of
ome countries and years of education with 1-year mortality.
Years of Education
p Value
rs
82)
>12–16 yrs
(n  1,633)
>16 yrs
(n  462)
.1) 579 (35.6) 171 (37.0) 0.0001
8) 20 (1.2) 12 (2.6) 0.0199
0) 16 (1.0) 7 (1.5) 0.0001
1) 59 (3.6) 13 (2.8) 0.0002
.8) 239 (14.6) 77 (16.7) 0.0001
1) 42 (2.6) 14 (3.0) 0.0001
9) 9 (0.6) 2 (0.4) 0.0001
5) 37 (2.3) 7 (1.5) 0.0001
2) 43 (2.6) 9 (2.0) 0.0001
9) 55 (3.4) 16 (3.5) 0.0001
Lower 95% CI
upper 95% CI
mortality (%)
0 12 14 16 18 20
Ed tiuca on
Patients With STEMI
ar mortality. CI  confidence interval; STEMI  ST-segment elevation myocardial–12 y
 6,9
67 (31
56 (0.
69 (1.
84 (4.
04 (15
14 (3.
65 (0.
46 (3.
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January 11, 2011:138–46 Education and Mortality in STEMIiscussion
ur study findings. This study demonstrates that lower
ES, as ascertained by years of completed education, was
ssociated with significantly poorer outcomes in subjects
ho received fibrinolysis after hospitalization for acute
TEMI. Particularly, mortality at 24 h, 30 days, and 1 year
ere all increased among subjects with STEMI with fewer
ears of education compared with those with more years of
ducation. Although fewer years of education was associated
ith adverse demographic, clinical, and presenting features
hat have been shown to portend a poor prognosis in
TEMI patients (27), years of education remained inde-
endently correlated with mortality, even after accounting
or these high-risk characteristics.
25%
30%
Subjects with unknown Education Status
>16 yrs
12-16 yrs
20%
 (%
)
 
8-12 yrs Edu
< 8 yrs Edu
15%
rt
al
ity
 ra
te
s
5%
10%M
or
0%
0 50 100 150
Days f
Figure 2 Relationship of Years of Education With 1-Year Morta
Note the significantly early hazard in those with education 8 years as well as in
elationship Between Years of Education and 1-Year Mortality RatTable 5 Relationship Between Years of Education and 1-Year M
Country (Compulsory Years of Education) <8 yrs
Overall 1-year mortality 17.5 (16.0–19.1)
United Kingdom (12 yrs) 22.1 (18.8–26.0) 1
Germany (13 yrs) 23.1 (18.0–29.4)
Sweden (10 yrs) 17.8 (14.9–21.2)
Italy (9 yrs) 16.9 (12.9–21.8) 1
New Zealand (12 yrs) 0
Poland (9 yrs) 17.6 (12.1–25.3) 1
Canada (11 yrs) 12.8 (8.5–19.0)
Australia (11 yrs) 8.5 (5.0–14.2)
United States (12 yrs) 9.9 (6.2–15.6)p value reflects differences across the 4 categories of years of education within a country. Data are giveAdditionally, our data indicate that the strength of the
elationship between years of education and mortality in
atients with STEMI varies among participating countries
ompared with the association observed among patients en-
olled in the United States. Nonetheless, for most countries
hat participated in the trial and reported information on level
f education for 500 subjects, years of education showed a
onsistent inverse relationship with 1-year mortality in subjects
ith STEMI. Even after adjusting for baseline characteristics
nd country of enrollment, years of education still remained
ignificantly associated with increased mortality at day 7 as well
s from day 8 through 1 year.
Thus, our data show that years of education is either an
mportant predictor of mortality or a surrogate marker of
easured or unmeasured variables that are strongly associ-
200 250 300 350
andomization
with information on years of education missing.
Enrolling Countrylity Rates by Enrolling Country
Years of Education
p Value*2 yrs >12–16 yrs >16 yrs
.2–8.5) 4.9 (3.9–6.1) 3.5 (2.2–5.6) 0.0001
.5–12.8) 3.5 (1.1–10.4) 0 0.0001
.0–10.7) 3.8 (1.3–11.5) 0 0.0001
.8–8.8) 2.6 (0.7–10.1) 0 0.0001
.5–18.7) 1.4 (0.2–9.3) 3.7 (0.5–23.5) 0.0025
.0–9.4) 3.5 (0.5–22.1) 0 0.4684
.7–15.1) 14.2 (7.8–25.6) 9.3 (3.1–26.2) 0.2523
.9–9.0) 4.3 (2.5–7.2) 1.6 (0.4–6.1) 0.0002
.1–7.5) 6.3 (2.1–18.1) 0 0.4765
.3–8.5) 5.1 (3.8–6.8) 4.2 (2.3–7.6) 0.0233rom R
lity
thosees byorta
8–1
7.8 (7
0.4 (8
8.6 (7
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1.5 (8
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7.3 (6n as event rates (95% confidence intervals).
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Education and Mortality in STEMI January 11, 2011:138–46ted with death up to 1 year after hospitalization for
TEMI. In fact, the prognostic importance of years of
ducation with mortality is further highlighted by the fact
hat the model chi-square for years of education (131.5) is
econd only to the model chi-square for age (172.3)—the
actor with the strongest relationship with early mortality.
omparisons with previous studies. Some previous studies
ave evaluated the relationship of years of education with
atient outcomes. Tofler et al. (28) examined data from
ILIS (Multicenter Investigation of the Limitation of Infarct
ize), comparing 453 patients who had completed at least high
chool with 363 who had not finished high school; all patients
ere from the United States and younger than 76 years of age
nd had experienced acute MI. The authors found that the
n-hospital and 4-year mortality rates were markedly higher for
ess educated patients than for those with more education
in-hospital mortality 13% vs. 5%, p 0.001; 4-year mortality,
6% vs. 17%, p  0.001). Fewer years of education remained
n independent correlate of long-term mortality after adjust-
ent for baseline features (p 0.024 after adjustment). Some
f the higher mortality among the less educated group was
hought to be related to lower rates of smoking cessation in this
ohort (38% vs. 49%; p  0.05).
Ruberman et al. (29) evaluated 1,739 male survivors of acute
I in the United States who were enrolled in the BHAT
Beta-blockers in Heart Attack Trial). The authors demon-
trated an inverse relationship between education and mortality
n this population, and further showed that this relationship
ndependent Correlates of 0- to 7-Day and 8- to 365-Day MortalityTable 6 Independent Correlates of 0- to 7-Day and 8- to 365-Da
Variable
0- to 7-Day Mortalit
Model Chi-Square HR
Age (yrs) 172.3 1.07 1.
Education (yrs) 131.5 0.86 0.
Killip class (vs. I) 58.1 —
II — 1.67 1.
III — 2.50 1.
IV — 4.83 3.
SBP (mm Hg) 95.9 0.97 0.
Country of enrollment (vs. United States)* 54.9 —
Australia — 0.29 0.
Canada — 0.50 0.
Germany — 1.06 0.
Italy — 1.03 0.
Poland — 2.32 1.
Sweden — 0.91 0.
United Kingdom — 1.10 0.
Heart rate (beats/min) 25.9 1.01 1.
MI location (vs. anterior) 13.6 —
Inferior — 0.68 0.
Other (nonanterior and noninferior) — 0.75 0.
eference cell for country by years of education is the United States. The 0- to 7-day model: interac
ingdom (p 0.0003), and Germany (p 0.0011). New Zealand was excluded from the statistical
ere excluded the interaction terms for years of education and country. The United States was the
nd country was statistically significant for Poland (p  0.0415). New Zealand was excluded from
eported here excluded the interaction terms for years of education and country. The United State
CI  confidence interval; HR  hazard ratio; other abbreviations as Table 2.eflected the gradient in prevalence of defined psychosocial pharacteristics (e.g., social isolation and high degree of life
tress were most common in the less-educated cohort).
Finally, in a small (n  197) study of hospitalized survivors
f MI in North Carolina, Kottke et al. (30) demonstrated
igher reinfarction rates and lower rates of return-to-work
mong patients with less education. Others have examined
ifferent domains of SES, including poverty (31), income (32),
ccupation (30), race and ethnicity (33), address and country of
esidence (34,35), insurance status (36), marital status (37), or
more complex deprivation score consisting of overcrowding,
nemployment, no car, and low occupational social class (35).
ach of these parameters has been shown to be related to
ortality in patients with acute MI.
Our study demonstrated a similar inverse relationship be-
ween lower SES, as measured by years of education, and
ortality in STEMI. Nonetheless, unlike previous investiga-
ions that included only a small number of patients (with very
ew events) and that in many cases relied on administrative data
hat did not allow for appropriate adjustments for baseline
onfounders, our study involved a large number of STEMI
atients in whom data on education, baseline features, treat-
ents, procedure use, and events (1,026 deaths at 1 year) were
rospectively collected, allowing reasonable adjustments for
aseline variables. Additionally, previous investigations mainly
ocused on single centers, regions, or countries. Because the
USTO-III was a multinational trial, we were able to examine
nd demonstrate the consistency for most parts of the relation-
hip between years of education and mortality among STEMI
ed Using Cox Proportional Hazard Modelrtality Derived Using Cox Proportional Hazard Model
el 8- to 365-Day Mortality Model
I p Value Model Chi-Square HR 95% CI p Value
8 0.0001 284.6 1.07 1.07–1.08 0.0001
8 0.0001 12.3 0.96 0.94–0.98 0.0005
0.0001 46.9 — — 0.0001
1 — — 1.72 1.41–2.10 —
7 — — 2.61 1.70–4.02 —
9 — — 3.36 1.56–7.25 —
7 0.0001 3.02 0.99 0.98–1.00 0.0818
0.0001 12.7 — — 0.0788
7 0.0004 — 0.93 0.66–1.30 0.6544
9 0.0027 — 1.08 0.82–1.41 0.5895
2 0.7353 — 0.83 0.60–1.14 0.2438
1 0.9149 — 1.21 0.81–1.79 0.3551
3 0.0001 — 1.61 1.13–2.30 0.0090
0 0.5938 — 0.95 0.70–1.29 0.7445
8 0.6042 — 1.06 0.79–1.43 0.6868
.2 0.0001 66.6 1.02 1.01–1.02 0.0001
0.0011 16.4 — — 0.0003
4 — — 0.70 0.58–0.83 —
3 — — 0.93 0.63–1.36 —
for years of education and country were statistically significant for Sweden (p 0.0001), United
because there were500 patients with data on education from this country. The model reported
nce cell for these comparisons. The 8- to 365-day model: interaction term for years of education
tistical models as there were 500 patients with data on education from this country. The model
he reference cell for these comparisons.Derivy Mo
y Mod
95% C
06–1.0
83–0.8
—
32–2.1
62–3.8
03–7.6
96–0.9
—
14–0.5
32–0.7
75–1.5
65–1.6
57–3.4
63–1.3
77–1.5
01–10
—
55–0.8
46–1.2
tion term
models
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the staatients with substantially different lifestyles, cultural influ-
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January 11, 2011:138–46 Education and Mortality in STEMInces, and health care systems that ranged from the
echnology-driven multipayer system in the United States to
he more conservative government-regulated single-payer sys-
em in Canada.
echanisms underlying the relationship between years
f education and mortality in patients with STEMI. Our
tudy was not specifically designed to address mechanisms
nderlying the propensity for worse clinical outcomes in
TEMI patients with fewer years of education. Nonetheless,
e were able to provide some insight into the contributions of
ome factors and possibly speculate on other explanations that
ink lower levels of education and mortality in STEMI pa-
ients. As described previously, the increased comorbid condi-
ions and adverse presenting features associated with fewer
ears of education may have accounted for some of the
bserved relationship with poorer outcomes in STEMI pa-
ients. Longer time to treatment, differences in medical ther-
pies, and lower revascularization rates (percutaneous coronary
ntervention or coronary artery bypass graft) may also have
ontributed to some of the excess mortality in the cohort with
ewer years of education. Moreover, factors not collected in our
tudy such as social isolation (living alone), life stress, poverty,
ack of insurance and inability to afford medications and/or lack
f access to subsequent care, lack of compliance with strategies
f secondary prevention including lifestyle changes may also
ave played an important role in the relationship between
ducational status and outcomes in patients with STEMI.
inally, education is closely linked with “health literacy,”
efined as the degree to which individuals have the capacity to
btain, process, and understand basic health information and
ervices needed to make appropriate health decisions (38).
ealth literacy is regarded as fundamental to patients’ quality
f care and safety; it is also a stronger predictor of health than
ge, income, employment status, or race (38) and may explain
ome of the association between education and outcomes seen
n the current study.
linical implications. Our study has a number of potential
linical implications. These data indicate that years of educa-
ion may be a predictor of short- and intermediate-term
ortality or a surrogate marker of measured or unmeasured
ariables that are strongly related to mortality in patients with
TEMI. Future research should certainly focus on under-
tanding the behavioral, social, biological, and physiological
ediators that link SES with cardiovascular disease and its
utcomes. Efforts to include measures of SES in all research on
ardiovascular disease in humans, including cross-sectional and
ongitudinal studies, clinical trials, and, when feasible, commu-
ity interventions, may help facilitate understanding of the
omplex link between SES and outcomes, as well as what
easure of SES has the strongest link to prognosis. Improving
ducation has the potential to improve health literacy and the
ealth outcomes of patients.
Finally, current comparisons of in-hospital mortality in
atients with CHD that adjust for baseline variables without
ccounting for educational status or other SES measures
39,40) may place institutions that care for large numbers of tocially underprivileged patients at a significant and inappro-
riate disadvantage, given that such comparisons are typically
sed as part of measuring, publicly reporting, and rewarding
uality. Our study shows educational status/SES to be the
ost important factor, after age, associated with early mortal-
ty. Adjusting for education/SES could help level the playing
eld for providers by recognizing differences among their
atient populations and allow fairer comparisons of outcome
easures as a surrogate for quality.
tudy limitations. This was a retrospective analysis, and our
ndings are best viewed as hypothesis generating. We used
ears of education as a marker of SES because it was most
ommonly used in previous studies, is easily obtainable, and
eldom changes beyond young adulthood. As such, we are
nable to provide insights into the relative strengths of the
ssociation between other markers of SES, as noted earlier, and
ortality in patients with STEMI. All patients were enrolled
n a clinical trial with strict inclusion and exclusion criteria and
eceived fibrinolytic therapy. Furthermore, almost all countries
n our study were developed countries. Thus, the applicability
f our study findings to STEMI patients in general or to those
n less developed countries remains to be evaluated in future
tudies. Finally, 1,927 patients were excluded from all our
nalyses as noted previously, predominantly because of incom-
lete data on years of education. However, to demonstrate the
elationship of the missing information on education with out-
omes, we compared 1-year mortality in patients with missing
nformation on education with those for whom this informa-
ion was available. Patients with missing information on edu-
ation had an almost 2-fold higher mortality compared with
hose included in this study (17.2% vs. 9.1%, p 0.0001) that
as even higher than those with8 years of education (Fig. 2).
t is likely that early mortality in the excluded group may have
recluded the time needed to obtain socioeconomic data.
lthough the effect of the bias that may have been inherited by
heir exclusion on the results of our study cannot be ascer-
ained, we believe that because missing information on educa-
ion was more common in patients who had higher mortality
nd because overall mortality was inversely linked to education,
he missing data on education were more likely to have biased
ur study findings toward failing to reject the null hypothesis
i.e., no relationship between education level and mortality).
onclusions
mong GUSTO-III STEMI patients treated with fibrino-
ysis, years of completed education (a measure of SES) was
nversely associated with significantly higher early and
-year mortality. Although the strength of relationship
etween years of education and mortality in these patients
aried among different countries, education remained inde-
endently related to mortality, even after adjusting for
aseline clinical variables and country of enrollment. Future
tudies should account for and investigate the behavioral,
ocial, biological, and physiological mechanisms underlying
his link between SES and cardiovascular disease outcomes.
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